Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Prediction and Management of Delayed Graft Function Based on Donor Criteria and LifePort Platform (Xi'anCri)

30. august 2016 opdateret af: Ding Xiaoming, First Affiliated Hospital Xi'an Jiaotong University

This is a prospective cohort study:

  1. First step: to establish a new scoring system for predication of delayed graft function(DGF) following kidney transplantation based on previous and new study data. The new scoring system is comprised of two parts: Xi'an Criteria of donor scoring system and kidney evaluation System based on Lifeport platform ).
  2. Second step: validate the new scoring system through prospective cohort study in our transplantation center and modify the scoring system if needed. Recruiting 300 patients, follow up at day 3, week 1, month 1, month 3, month 6 and month 12. Patients will be followed for Cr30cl, DGF,primary non-function (PNF), acute rejection (AR), graft survival and patient survival
  3. Step 3: Further validate the new scoring system in six other transplantation centers and developing a software in the end. Recruiting 300 patients, follow up at day 3, week 1, month 1, month 3, month 6 and month 12. Patients will be followed for Cr30cl, DGF, PGF, AR, graft survival and patient survival

Studieoversigt

Status

Ukendt

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Subjects are enrolled to collect the data of donors and recipients. Investigators also collect the data of recipients or donated organs as following: physiological and biochemical indexes, machine perfusion parameters, and the other factors effected on renal transplant outcomes. A Cox proportional hazards model and multiple linear regression analysis will be applied to examine the correlation among the univariate and multivariate. Based on the above analysis to improve the new scoring system, Lifeport work platform evaluation system and donor kidney quality evaluation system. Then, a multi-center clinical trial will be started to improve and verify the new scoring system. Finally, a donor kidney evaluation APP will be developed based on the scoring system and the database of clinical trials. An applicaiotion (APP) will be popularized the national transplant surgeons.

Undersøgelsestype

Observationel

Tilmelding (Forventet)

1000

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

    • Shaanxi
      • Xi'an, Shaanxi, Kina, 710061
        • Rekruttering
        • First Affiliated Hospital Xi'an Jiaotong University
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 65 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

patients assigned the deceased donor kidney to transplant in the waiting list.

Beskrivelse

Inclusion Criteria:

Donor

  • 1. Comply with the national donation after citizen death guideline
  • 2. No high risk activities: such as history of drug abuse, history of intravenous drug use and risky sexual behavior
  • 3. No malignant melanoma, metastatic cancer, or incurable cancer; some of the early stages of cancer after a successful treatment can also be considered
  • 4. No activity of untreated systemic bacterial, viral or fungal infection;
  • 5. Patients definitely identified

Recipient:

  • 1. 65 y old ≥Age> = 18 years old, male or female
  • 2. BMI<26
  • 3. Renal transplantation first time
  • 4. Not in pregnancy or lactation, pregnancy test was negative, and promise not to be pregnant during treatment.
  • 5. Before the clinical trial, Patient sign informed consent voluntarily

Exclusion Criteria:

Donor

  • 1. Older than 65 years old
  • 2.Serum hepatitis B virus (HBV), hepatitis C virus (HCV), HIV positive
  • 3.Donor kidney cold storage time over 30 hours
  • 4.Warm ischemia time over 20 minutes
  • 5.Other reagents are added perfusion for regulation of donor renal function

Recipient:

  • 1.Involved in other study.
  • 2.Double organ or multi-organ transplant
  • 3.A,B,O blood type-incompatible

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
delayed graft function
Tidsramme: 7 days after renal transplant
7 days after renal transplant
Transplant nephrectomy
Tidsramme: 1 year after reanl transplant
1 year after reanl transplant

Sekundære resultatmål

Resultatmål
Tidsramme
Abnormal serum creatinine
Tidsramme: Serum creatinine did not return to the normal range within the first 30 days
Serum creatinine did not return to the normal range within the first 30 days
Renal dysfunction caused by the acute rejection
Tidsramme: within the first 3 months
within the first 3 months
lung infection lead to death
Tidsramme: within the first 1 year
within the first 1 year
Renal dysfunction caused by Surgical complications
Tidsramme: within the first 3 months
within the first 3 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: xiaoming D Ding, PhD, First Affiliated Hospital Xi'an Jiaotong University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. januar 2016

Primær færdiggørelse (Forventet)

1. december 2018

Studieafslutning (Forventet)

1. december 2019

Datoer for studieregistrering

Først indsendt

19. august 2016

Først indsendt, der opfyldte QC-kriterier

19. august 2016

Først opslået (Skøn)

24. august 2016

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

1. september 2016

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

30. august 2016

Sidst verificeret

1. august 2016

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • XAC-01

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .